行情

XTNT

XTNT

Xtant医控股
AMEX

实时行情|Nasdaq Last Sale

1.620
-0.100
-5.81%
休市 16:00 06/18 EDT
开盘
1.700
昨收
1.720
最高
1.710
最低
1.610
成交量
5.25万
成交额
--
52周最高
6.58
52周最低
0.7100
市值
1.40亿
市盈率(TTM)
-5.4181
分时
5日
1月
3月
1年
5年
到2027年,药物洗脱支架市场规模预计将达到约40.50亿美元|弧
pune, India, Wed, 12 May 2021 03:25:40 / Comserve Inc. / -- The global drug eluting stent market size is anticipated to reach around US$ 4,050 Mn by 2027 and...
Comserve · 05/12 07:27
Brief-Xtant Medical宣布第一季度收入为1,250万美元
reuters.com · 05/11 12:51
BRIEF-Xtant Medical Holdings Files For Mixed Shelf Of Up To $150 Mln
reuters.com · 05/11 12:29
每日生物技术动向:FDA授权辉瑞-BioNTech COVID-19疫苗用于青少年,礼来公司进行研发合作,疫苗库存Novavax,收益的Inovio Sink
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10)
Benzinga · 05/11 11:54
Xtant Medical Holdings,Inc.普通股第一季度销售额1,254万美元,预估亏损1,402万美元
Xtant Medical Holdings, Inc. Common Stock (AMEX:XTNT) reported quarterly sales of $12.54 million which missed the analyst consensus estimate of $14.02 million by 10.54 percent. This is a 15.13 percent decrease over
Benzinga · 05/11 11:41
10-Q:XTANT MEDICAL HOLDINGS,INC。
(EDGAR Online via COMTEX) -- ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations This Management's Discussion and...
Edgar Online - (EDG = 10Q, 10K) · 05/11 11:33
Xtant Medical可能进行的证券发行的文件档案架注册;股价暴跌12%
MT Newswires · 05/11 10:04
计划于2021年5月11日盈利
  Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter.
Benzinga · 05/11 08:13
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解XTNT最新的财务预测,通过XTNT每股收益,每股净资产,每股现金流等数据分析Xtant医控股近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测XTNT价格均价为1.000,最高价位1.000,最低价为1.000。
EPS
机构持股
总机构数: 14
机构持股: 1,186.29万
持股比例: 13.68%
总股本: 8,670.73万
类型机构数股数
增持
4
2.26万
建仓
1
15
减持
2
5,678
平仓
0
0
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设备、用品及经销
-1.07%
医疗设备和用品
-0.86%
高管信息
President/Chief Executive Officer/Director
Sean Browne
Chief Financial Officer/Vice President - Finance
Greg Jensen
Chief Operating Officer
Darrel Holmes
Senior Vice President
Kevin Brandt
Chief Scientific Officer
Gregory Juda
Director
John Bakewell
Director
Michael Eggenberg
Director
Robert McNamara
Director
Jeffrey Peters
Director
Matthew Rizzo
暂无数据
XTNT 简况
Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.

微牛提供Xtant Medical Holdings Inc(AMEX-XTNT)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的XTNT股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易XTNT股票基本功能。